![Page 1: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/1.jpg)
Nader Moazami, MD
Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH
HeartMate II Pump Thrombosis
![Page 2: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/2.jpg)
From Bedside Observation….From Bedside Observation….From Bedside Observation….From Bedside Observation….
• How it beganHow it began
• What evolvedWhat evolved
• What is the dataWhat is the data
• What was our responsibilityWhat was our responsibility
• What comes nextWhat comes next
![Page 3: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/3.jpg)
Initial Cleveland Clinic Awareness to Action
Mid-2011• Concern about possible increasing incidence
of pump thrombosis• Formation of a “Thrombosis” group lead by
Thoratec• Last meeting of this group in Atlanta
(2/15/2013) several implanting institutions report similar concern
2/22/2013• Chair requests thorough investigation of CCF
experience
![Page 4: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/4.jpg)
Definition
Confirmed• Thrombus within blood contacting
surfaces of device inflow cannulae or outflow conduit or grafts
Suspected• Suggestive pump-related malfunction
• Hemolysis,Unexplained “heart” failure, Abnormal pump parameters
• All cases with anatomic reason excluded
![Page 5: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/5.jpg)
Pump Thrombosis
8 Confirmed
16 Suspected
Timing• 8 before 4th quarter 2011
5 months to 3.4 years post-implant
• 16 since then10 within 3 months post-implant
![Page 6: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/6.jpg)
Question
Is there a relation between risk of pump thrombosis and date of implant?
Confounding factors• Surgeons
• Anticoagulation protocol
![Page 7: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/7.jpg)
Parallel Approach
Random Survival Forest• Non-parametric assumption-free
method
• Machine learning
Temporal Decomposition Model• Parametric
• Machine learning
![Page 8: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/8.jpg)
Free of Thrombosis at 3 Mo.
%%
HeartMate II Implant DateHeartMate II Implant Date
![Page 9: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/9.jpg)
20
40
60
80
100
0 6 12 18 24 30 36 42
Free of Thrombosis
%%
Months after HeartMate II ImplantMonths after HeartMate II Implant
10/04 – 09/11
09/11– 02/13
![Page 10: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/10.jpg)
10
20
30
40
0 6 12 18 24 30 36 42
Risk of Pump Thrombosis
%/y%/y
Months after HeartMate II ImplantMonths after HeartMate II Implant
![Page 11: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/11.jpg)
LDH
mg/dLmg/dL
Months after ImplantMonths after Implant
Before 9/11
Since 9/11Thrombosis
![Page 12: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/12.jpg)
AC:21,122 measurements, 296 devices21,122 measurements, 296 devices
INRINR
Months after ImplantMonths after Implant
Before 9/11
Since 9/11Thrombosis
![Page 13: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/13.jpg)
Single Center Data submitted for Publication May 2013
Single Center Data submitted for Publication May 2013
• The principal shortcoming of your study is that it is based on the experience of a The principal shortcoming of your study is that it is based on the experience of a single centersingle center. . All of the reviewers of your manuscript All of the reviewers of your manuscript
raised this issue in their comments to the editors. In order to publish your work, we will need solid raised this issue in their comments to the editors. In order to publish your work, we will need solid confirmation of your confirmation of your findings from the experience of other centers, registries, or data basesfindings from the experience of other centers, registries, or data bases. . There is concern that center-specific characteristics or practices at Cleveland Clinic may be at play, and it is essential that your study include a There is concern that center-specific characteristics or practices at Cleveland Clinic may be at play, and it is essential that your study include a much broader dataset in order to provide confirmation/validation of the findings at your center. The editors believe that your findings are much broader dataset in order to provide confirmation/validation of the findings at your center. The editors believe that your findings are
interesting and potentially quite important. With that said, we interesting and potentially quite important. With that said, we do not want to take a chance on do not want to take a chance on misleading the medical community without convincing validation of your misleading the medical community without convincing validation of your findingsfindings. .
• In order to publish your work, we will need solid confirmation of your findings from the In order to publish your work, we will need solid confirmation of your findings from the experience of other centers, experience of other centers, registries, or data basesregistries, or data bases. . There is concern that center-specific characteristics or practices at Cleveland Clinic may be There is concern that center-specific characteristics or practices at Cleveland Clinic may be
at play, and it is essential that your study include a much broader dataset in order to provide confirmation/validation of the findings at your at play, and it is essential that your study include a much broader dataset in order to provide confirmation/validation of the findings at your
centercenter. .
• Statistical Reviewer Statistical Reviewer Comments for the Author: Comments for the Author:
This paper reports a dramatic and alarming increase in Heartmate II pump thrombosis after September, 2011 at the Cleveland Clinic. This paper reports a dramatic and alarming increase in Heartmate II pump thrombosis after September, 2011 at the Cleveland Clinic. This This is important information that should be shared widely. is important information that should be shared widely.
![Page 14: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/14.jpg)
CDWP Cooperative ConsortiumCDWP Cooperative Consortium
CDWP Cooperative ConsortiumCDWP Cooperative Consortium
• Centers combined data of all HM II device Centers combined data of all HM II device implants and reported CONFIRMED PUMP implants and reported CONFIRMED PUMP THROMBOSISTHROMBOSIS- CCF10/2004 – 2/2013 CCF10/2004 – 2/2013 3/5/2013*3/5/2013* n=296 n=296- Duke 5/2005 – 5/2013 Duke 5/2005 – 5/2013 5/16/20135/16/2013 n=292 n=292- Wash U 1/2004 – 4/2013 Wash U 1/2004 – 4/2013 9/10/20139/10/2013 n=307 n=307- Penn 11/2005 – Penn 11/2005 – 10/17/201310/17/2013 n=163 n=163
- 1058 Devices from 4 centers1058 Devices from 4 centers- *Non-uniform closing dates*Non-uniform closing dates
![Page 15: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/15.jpg)
Occurrence and Incidence of Confirmed Pump Thrombosis Stratified According to Implantation Date.
Starling RC et al. N Engl J Med 2013. DOI: 10.1056/NEJMoa1313385
![Page 16: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/16.jpg)
CONFIRMED Pump Thrombosis at 3 Months after HeartMate II Implantation.
Starling RC et al. N Engl J Med 2013. DOI: 10.1056/NEJMoa1313385
![Page 17: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/17.jpg)
Overall Occurrence of CONFIRMED Pump Thrombosis after HeartMate II Implantation.
Starling RC et al. N Engl J Med 2013. DOI: 10.1056/NEJMoa1313385
7.5%4.7% 12.3%
![Page 18: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/18.jpg)
Percentage of Devices with Confirmed Pump Thrombosis at 3 Months after HeartMate II Implantation.
Rame JE et al. N Engl J Med 2014;370:1466-1467.
Penn
4 centers
![Page 19: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/19.jpg)
Mortality According to Management Strategy after Confirmed Pump Thrombosis.
Starling RC et al. N Engl J Med 2013. DOI: 10.1056/NEJMoa1313385
![Page 20: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/20.jpg)
Elevated Lactate Dehydrogenase (LDH) Levels within 3 Months after HeartMate II Implantation.
Starling RC et al. N Engl J Med 2013. DOI: 10.1056/NEJMoa1313385
![Page 21: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/21.jpg)
INTERMACS Registry Analysis Pump ThrombosisLDH
Kirklin J. JHLT 2013
66% missing LDH
8.2% Events (192/2329)
21.4% Events LDH >1000(41/192)
![Page 22: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/22.jpg)
Early HM 2 Pump Thrombosis has Early HM 2 Pump Thrombosis has Increased. Why?Increased. Why?
Early HM 2 Pump Thrombosis has Early HM 2 Pump Thrombosis has Increased. Why?Increased. Why?
• Four Four EXPERIENCED EXPERIENCED centers with consistent centers with consistent observations-not only isolated to these 4 centersobservations-not only isolated to these 4 centers- Are patients different?Is reporting different? Is Are patients different?Is reporting different? Is
management different?management different?• Is the device different? Is the device different?
- >17,000 implants worldwide (50-100/wk)>17,000 implants worldwide (50-100/wk)- Pump thrombosis seen with previous mechanical Pump thrombosis seen with previous mechanical
pivot-based bearing devicespivot-based bearing devices- Pathological reports show 60-70% laminated Pathological reports show 60-70% laminated
thrombus at inlet (front-loaded) bearingthrombus at inlet (front-loaded) bearing- Do some pumps have a lower tolerance to sub Do some pumps have a lower tolerance to sub
therapeutic anticoagulation, INR<2?therapeutic anticoagulation, INR<2?
![Page 23: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/23.jpg)
PUMP POWER ELEVATIONPUMP POWER ELEVATIONPUMP POWER ELEVATIONPUMP POWER ELEVATION
1.3 1.47 1.64 1.81 1.98 2.15 2.32 2.49 2.66 2.83 34
6
8
10
12
Days Post ImplantP
ow
er
(W)
4.6 5.02 5.44 5.86 6.28 6.7 7.12 7.54 7.96 8.38 8.84
6
8
10
12
Days Post Implant
Po
we
r (W
)
Group 1
Group 2
Group 3
1.4 1.91 2.42 2.93 3.44 3.95 4.46 4.97 5.48 5.99 6.54
6
8
10
12
Days Post Implant
Po
we
r (W
)N=9
N=8
N=2
![Page 24: Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis](https://reader035.vdocuments.us/reader035/viewer/2022070411/56649cd95503460f949a30ab/html5/thumbnails/24.jpg)
What is Next For Us?What is Next For Us?What is Next For Us?What is Next For Us?• Collaborative data collection: Cleveland Clinic, Wash Collaborative data collection: Cleveland Clinic, Wash
Univ, Duke, Penn, ColumbiaUniv, Duke, Penn, Columbia• All HM II implants through Dec 31, 2013All HM II implants through Dec 31, 2013• 90 Days follow up: common closing date March 31, 90 Days follow up: common closing date March 31,
20142014• Thoratec invited to collaborate to provide all device Thoratec invited to collaborate to provide all device
related variablerelated variable• Extensive patient level variables from INTERMACS and Extensive patient level variables from INTERMACS and
site data collectionsite data collection• Pump measurements via xrays Pump measurements via xrays • Data analysis team led by Eugene Blackstone MDData analysis team led by Eugene Blackstone MD• IRB approvals in progressIRB approvals in progress